Levels of Free Fatty Acids (FFA) are associated with insulin resistance but do not explain the relationship between adiposity and insulin resistance in hispanic americans: The IRAS family study

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages 3285-3291

  Miller, Melissa R ^a   Pereira, Rocio I ^b,c   Langefeld, Carl D ^d   Lorenzo, Carlos ^e   Rotter, Jerome I ^f   Chen, Yii Der Ida ^f   Bergman, Richard N ^g   Wagenknecht, Lynne E ^d   Norris, Jill M ^a   Fingerlin, Tasha E ^a  

^a Global Health and Health Disparities   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f Medical Genetics Institute   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FAMILY STUDY; FATTY ACID ANALYSIS; FEMALE; HISPANIC; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; OBESITY; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADIPOSITY; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FATTY ACIDS, NONESTERIFIED; FEMALE; GENOTYPE; HISPANIC AMERICANS; HUMANS; INSULIN; INSULIN RESISTANCE; LIKELIHOOD FUNCTIONS; LIPIDS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; TEXAS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866145286     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1318     Document Type: Article

References (40)

1. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C 1993 Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992 (Pubitemid 24015042)
2. Haffner SM, Miettinen H, Gaskill SP, Stern MP 1995 Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386-1391
3. Weyer C, Bogardus C, Pratley RE 1999 Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197-2203 (Pubitemid 29521850)
4. Lorenzo C, Wagenknecht LE, D'Agostino Jr RB, Rewers MJ, Karter AJ, Haffner SM 2010 Insulin resistance, β-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population. Diabetes Care 33:67-72
5. Boden G 1997 Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10 (Pubitemid 27009941)
6. Boden G 2008 Obesity and free fatty acids. Endocrinol Metab Clin North Am 37:635-646, viii-ix
7. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI 1999 Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259 (Pubitemid 29053143)
8. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI 2002 Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236 (Pubitemid 36042170)
9. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J 2002 Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J Biol Chem 277:48115-48121 (Pubitemid 35470759)
10. Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z, Ruderman N 2005 Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver. Diabetes 54:3458-3465 (Pubitemid 43334336)
11. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, Wajchenberg BL 1999 Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48:1836-1841 (Pubitemid 29415205)
12. Gordon ES 1960 Non-esterified fatty acids in the blood of obese and lean subjects. Am J Clin Nutr 8:740-747
13. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD 1988 Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024 (Pubitemid 19033579)
14. Björntorp P, Bergman H, Varnauskas E 1969 Plasma free fatty acid turnover rate in obesity. Acta Med Scand 185:351-356
15. Björntorp P 1991 Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143
16. Mårin P, Andersson B, Ottosson M, Olbe L, Chowdhury B, Kvist H, Holm G, Sjöström L, Björntorp P 1992 The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism 41:1242-1248
17. Arner P 1995 Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 27:435-438
18. Arner P 1997 Regional adipocity in man. J Endocrinol 155:191-192 (Pubitemid 27475805)
19. Henkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, Langefeld CD, Mitchell BD, Norris JM, Rewers M, Saad MF, Stamm E, Wagenknecht LE, Rich SS 2003 Genetic epidemiology of insulin resistance and visceral adiposity: the IRAS Family Study design and methods. Ann Epidemiol 13:211-217 (Pubitemid 36390342)
20. Wagenknecht LE, Mayer EJ, Rewers M, Haffner S, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R 1995 The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design, and recruitment results. Ann Epidemiol 5:464-472
21. Steil GM, Volund A, Kahn SE, Bergman RN 1993 Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 42:250-256 (Pubitemid 23045028)
22. Noma A, Okabe H, Kita M 1973 A new colorimetric micro-determination of free fatty acids in serum. Clin Chim Acta 43:317-320
23. Bergman RN, Finegood DT, Ader M 1985 Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-86
24. Holland PW 1988 Causal inference, path analysis, and recursive structural equations models. Sociol Methodol 18:449-493
25. MacKinnon DP 1994 Analysis of mediating variables in prevention and intervention research. NIDA Res Monogr 139:127-153
26. Shulman GI 2000 Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176 (Pubitemid 30483118)
27. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE 1996 Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 45:742-748
28. U.S. Centers for Disease Control and Prevention 2010 Health, United States, 2009. Atlanta: Centers for Disease Control and Prevention
29. Centers for Disease Control and Prevention 2004 Prevalence of diabetes among Hispanics-selected areas, 1998-2002. MMWR Morb Mortal Wkly Rep 53:941-944
30. Franks PW, Wong MY, Luan J, Mitchell J, Hennings S, Wareham NJ 2002 Non-esterified fatty acid levels and physical inactivity: the relative importance of low habitual energy expenditure and cardiorespiratory fitness. Br J Nutr 88:307-313 (Pubitemid 34987668)
31. Hernandez TL, Sutherland JP, Wolfe P, Allian-Sauer M, Capell WH, Talley ND, Wyatt HR, Foster GD, Hill JO, Eckel RH 2010 Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet. Am J Clin Nutr 91:578-585
32. Chung BH, Hennig B, Cho BH, Darnell BE 1998 Effect of the fat composition of a single meal on the composition and cytotoxic potencies of lipolytically releasable free fatty acids in postprandial plasma. Atherosclerosis 141:321-332 (Pubitemid 28539640)
33. Yu YH, Ginsberg HN 2005 Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 96:1042-1052 (Pubitemid 40791376)
34. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S 1999 Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol 276(2 Pt 1):E278-E284 (Pubitemid 29100583)
35. Mittendorfer B, Magkos F, Fabbrini E, Mohammed BS, Klein S 2009 Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity 17:1872-1877
36. Shoelson SE, Herrero L, Naaz A 2007 Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169-2180 (Pubitemid 46693756)
37. Shoelson SE, Lee J, Goldfine AB 2006 Inflammation and insulin resistance. J Clin Invest 116:1793-1801 (Pubitemid 44033299)
38. Tripathy D, Mohanty P, Dhindas S, Syed T, Ghanim H, Aljada A, Dandona P 2003 Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52:2882-2887 (Pubitemid 37466856)
39. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM 1995 Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 96:88-98
40. Frayn KN 2000 Visceral fat and insulin resistance - causative or correlative? Br J Nutr 83(Suppl 1):S71-S77 (Pubitemid 30319085)